Business Opportunities in the shift to data driven personalized medicine in Europe

BUSINESS SWEDEN INVITES YOU TO BREAKFAST SEMINARS AND BUSINESS DISCUSSIONS IN APRIL 2024 (STOCKHOLM, GÖTEBORG, OR LUND)

The developments in data-driven personalised medicine on a global scale present significant opportunities for Swedish companies. The pace of progress may vary, but the global trend is towards integrating data-driven approaches to optimise healthcare delivery and outcomes.

We will present our latest report where we look at the drivers of the shift to data driven personalised medicine in different markets, and some of the business opportunities it represents for Swedish healthcare companies in Europe. Join us to find out more about PeCan in France, DiGa in Germany, EHDS, or European harmonization attempts of Digital Health Technology Assessment, for example. We will also talk about upcoming joint activities in Europe for 2024 and you will have the possibility of individual discussions about your company’s specific opportunities and pain points on the European markets.

We invite companies in all stages of their international expansion to join . Business Sweden is committed to supporting your international expansion, providing you with the necessary tools, information, and network.

For questions, please contact britta.stenson@business-sweden.se

This seminar series is made possible through the support of our partners; Karolinska Institutet Science Park, GoCo Health Innovation City and LU Innovation. 

The events are free of charge but registration in advance is mandatory.